Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

Elevance Health, Inc. (ELV) — XLV Health Care · S&P 500 Profile |信諾健康公司介紹

health-careS&P500xlvxlv-top-25
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

Elevance Health, Inc. (ELV) — Business, History & S&P 500 Profile |信諾健康公司介紹

Elevance Health company profile · managed health care & Carelon services · history · financial snapshot · S&P 500 rank #135 · 信諾健康公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Oct 31, 2026
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$90.76B
Oct 31, 2026 · StockAnalysis
S&P 500 WEIGHT
0.13%
Rank #135 · Oct 31, 2026 (Slickcharts)
FY2025 TOTAL REVENUES
$199.13B
+12.5% YoY · operating revenue $197.58B
FY2025 NET INCOME
$5.66B
Diluted EPS $25.21 · ~45.2M medical members

SNAPSHOT

TickerELV (NYSE)
CompanyElevance Health, Inc.
GICS sector / industryHealth Care (XLV) / Managed Health Care
S&P 500 rank (by weight)#135 · 0.13% (Oct 31, 2026)
Sector rank (by market cap)#21 in Health Care (Oct 31, 2026)
HeadquartersIndianapolis, Indiana
Founded1946, in Indianapolis (present form from the 2004 Anthem–WellPoint merger)
CEOGail K. Boudreaux (president and chief executive officer)
EmployeesApproximately 97,100 (71,900 U.S., 25,200 international; Dec 31, 2025, FY2025 10-K)
Market cap$90.76B (Oct 31, 2026)
SEC filingsEDGAR — CIK 0001156039

WHAT IT DOES

Elevance Health, formerly Anthem, Inc. until June 2022, is one of the largest health insurers in the United States by medical membership, serving approximately 45.2 million medical members through affiliated health plans, including Anthem Blue Cross and Blue Shield plans and Wellpoint. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association.

The company reports in Health Benefits and Carelon. Health Benefits — premiums of $159.46B plus service fees — produced FY2025 operating revenue of $167.09B and operating gain of $4.16B, down 33% year on year as benefit expense rose to $143.89B. CarelonRx (pharmacy services, product revenue $24.47B) produced $43.40B of operating revenue and $2.42B of operating gain; Carelon Services produced $28.32B and $0.96B. Total operating revenue was $197.58B and total operating gain $7.20B.

FY2025 total revenues were $199.13B, against $177.01B in FY2024, and net income was $5.66B, or $25.21 diluted EPS, against $25.68 in FY2024.

BUSINESS SEGMENTS — FY2025 OPERATING REVENUE

SegmentOperating revenueShareYoY
Health Benefits$167.09B84.6%+11.2%
CarelonRx$43.40B22.0%+20.7%
Carelon Services$28.32B14.3%+57.7%
Corporate & Other$0.46B0.2%+49.8%
Eliminations−$41.69B−21.1%—
Total operating revenue$197.58B100%+12.8%
Source: Elevance Health FY2025 Form 10-K segment note (fiscal year ended Dec 31, 2025). Shares are of total operating revenue; segment revenues sum above the total because affiliated revenues are eliminated. Health Benefits detail: premiums $159.46B, service fees $7.64B. Carelon detail: CarelonRx product revenue $24.47B; Carelon Services operating revenue $28.32B includes affiliated revenue. Total revenues ($199.13B) exceed operating revenue by net investment and other income.

HISTORY

YearMilestone
1946Founded in Indianapolis as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc.
2004Merger of Anthem and WellPoint Health Networks creates the present company form
2022Renamed Elevance Health, Inc. (June 2022), from Anthem, Inc.
2025FY2025: approximately 45.2 million medical members; total revenues $199.13B; net income $5.66B

COMPETITIVE POSITION

  • Blue Cross Blue Shield scale — the largest for-profit managed care company in the Blue Cross Blue Shield Association, with the brand and provider networks that scale brings.
  • Carelon diversification — CarelonRx and Carelon Services ($71.72B combined operating revenue) sell pharmacy and services to third parties as well as to Health Benefits, diversifying beyond premiums.
  • Government mix — Medicare, Medicaid and FEP membership alongside employer-group and individual plans spreads regulatory exposure across programs.
  • Competition — UnitedHealth Group, CVS Health/Aetna, Cigna and Humana contest the same employer, Medicare and Medicaid membership; medical-cost trends decide margins for all of them.

FINANCIAL SNAPSHOT — FY2025

Total revenues$199.13B (vs $177.01B in FY2024)
Total operating revenue$197.58B (+12.8% YoY)
Total operating gain$7.20B (vs $7.86B in FY2024, −8.4%)
Health Benefits operating gain$4.16B (vs $6.24B in FY2024)
Net income$5.66B
Diluted EPS$25.21 (vs $25.68 in FY2024)
Medical membersApproximately 45.2 million
EmployeesApproximately 97,100 (Dec 31, 2025)
Fiscal yearEnds Dec 31 (FY2025 ended Dec 31, 2025)
Source: Elevance Health FY2025 Form 10-K (filed Feb 6, 2026; fiscal year ended Dec 31, 2025), consolidated statements and segment note. FY2024 comparatives are the 10-K comparatives.

KEY RISKS

  • Medical-cost trend — benefit expense reached $143.89B in FY2025 and cut Health Benefits operating gain by a third; trend above pricing flows straight to margin.
  • Medicaid redeterminations — eligibility redeterminations that began in April 2023 continued to move Medicaid membership and mix through FY2025.
  • Regulatory and MLR rules — approximately 53.5% of premium revenue and 18.7% of medical membership were subject to minimum medical-loss-ratio regulations in FY2025.
  • Carelon execution — Carelon’s rapid growth (Services +57.7%) depends on third-party wins and integration; a slowdown removes the diversification offset.
  • Provider and drug costs — hospital, physician and pharmacy (including specialty drug) price growth pressures every segment’s margin.

WHY IT MATTERS FOR THE S&P 500

Elevance Health is the S&P 500’s managed-care read on medical costs: at a 0.13% index weight and #21 in Health Care by market cap, its benefit-expense trend and membership moves preview what the whole managed-care group will report.

Its Carelon arm also makes it a read on pharmacy and health-services outsourcing — the part of health care that grows even when insurance margins compress.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price — Oct 31, 2026 crawl) · StockAnalysis (market cap — Oct 31, 2026 crawl)
FinancialsElevance Health FY2025 Form 10-K (SEC EDGAR, filed Feb 6, 2026; fiscal year ended Dec 31, 2025)
Sector classificationGICS via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

Elevance

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

代碼ELV(NYSE)
公司Elevance Health, Inc.
GICS 板塊/行業醫療保健(XLV)/管理式醫療保健
標普500排名(按權重)#135 · 0.13%(2026 年 10 月 31 日)
板塊內排名(按市值)醫療保健第 #21(2026 年 10 月 31 日)
總部美國印第安納州印第安納波利斯
成立1946 年,於印第安納波利斯(現有形態源自 2004 年 Anthem 與 WellPoint 合併)
行政總裁Gail K. Boudreaux(總裁兼行政總裁)
員工約 97,100(美國 71,900、國際 25,200;2025 年 12 月 31 日,FY2025 10-K)
市值$90.76B(2026 年 10 月 31 日)
SEC 申報EDGAR — CIK 0001156039

業務概覽

信諾健康(2022 年 6 月前稱 Anthem, Inc.)是美國按醫療會員計最大的健康保險公司之一,透過附屬健康計劃(包括 Anthem Blue Cross and Blue Shield 計劃與 Wellpoint)服務約 4,520 萬名醫療會員,是 Blue Cross Blue Shield Association 內最大的營利性管理式醫療保健公司。

公司分健康福利與 Carelon 報告。健康福利——保費 $159.46B 加服務費——FY2025 營業收入 $167.09B,營業利潤 $4.16B,同比下跌 33%,因福利支出升至 $143.89B。CarelonRx(藥房服務,產品收入 $24.47B)營業收入 $43.40B,營業利潤 $2.42B;Carelon Services 營業收入 $28.32B,營業利潤 $0.96B。營業收入合計 $197.58B,營業利潤合計 $7.20B。

FY2025 總收入 $199.13B,FY2024 為 $177.01B;淨利潤 $5.66B,攤薄每股盈利 $25.21,FY2024 為 $25.68。

業務板塊 — FY2025 營業收入

板塊營業收入佔比同比
健康福利$167.09B84.6%+11.2%
CarelonRx$43.40B22.0%+20.7%
Carelon Services$28.32B14.3%+57.7%
企業及其他$0.46B0.2%+49.8%
抵銷−$41.69B−21.1%—
營業收入合計$197.58B100%+12.8%
來源:信諾健康 FY2025 Form 10-K 板塊附註(財政年度截至 2025 年 12 月 31 日)。佔比按營業收入合計計算;板塊收入合計高於總額,因附屬收入已被抵銷。健康福利明細:保費 $159.46B、服務費 $7.64B。Carelon 明細:CarelonRx 產品收入 $24.47B;Carelon Services 營業收入 $28.32B 含附屬收入。總收入($199.13B)高於營業收入,差額為淨投資及其他收入。

歷史沿革

年份里程碑
1946於印第安納波利斯創立,初名 Mutual Hospital Insurance Inc. 與 Mutual Medical Insurance Inc.
2004Anthem 與 WellPoint Health Networks 合併,形成現有公司形態
2022更名為 Elevance Health, Inc.(2022 年 6 月),前稱 Anthem, Inc.
2025FY2025:醫療會員約 4,520 萬;總收入 $199.13B;淨利潤 $5.66B

競爭地位

  • Blue Cross Blue Shield 規模——Blue Cross Blue Shield Association 內最大的營利性管理式醫療公司,品牌與供應商網絡帶來規模優勢。
  • Carelon 多元化——CarelonRx 與 Carelon Services(合計營業收入 $71.72B)除服務健康福利外,亦向第三方銷售藥房與服務,令收入超越保費。
  • 政府組合——除僱主團體與個人計劃外,尚有 Medicare、Medicaid 與 FEP 會員,分散各計劃的監管敞口。
  • 競爭——聯合健康、CVS Health/Aetna、Cigna 與 Humana 爭奪同一批僱主、Medicare 與 Medicaid 會員;醫療成本趨勢決定所有業者的利潤。

財務快照 — FY2025

總收入$199.13B(FY2024 為 $177.01B)
營業收入合計$197.58B(同比 +12.8%)
營業利潤合計$7.20B(FY2024 為 $7.86B,−8.4%)
健康福利營業利潤$4.16B(FY2024 為 $6.24B)
淨利潤$5.66B
攤薄每股盈利$25.21(FY2024 為 $25.68)
醫療會員約 4,520 萬
員工約 97,100(2025 年 12 月 31 日)
財政年度截至 12 月 31 日(FY2025 截至 2025 年 12 月 31 日)
來源:信諾健康 FY2025 Form 10-K(2026 年 2 月 6 日申報;財政年度截至 2025 年 12 月 31 日),合併報表與板塊附註。FY2024 數字為 10-K 比較數。

主要風險

  • 醫療成本趨勢——福利支出在 FY2025 達 $143.89B,令健康福利營業利潤下跌三分之一;趨勢高於定價即直接侵蝕利潤。
  • Medicaid 重新核定——自 2023 年 4 月開始的資格重新核定在 FY2025 期間持續影響 Medicaid 會員與組合。
  • 監管與 MLR 規則——FY2025 約 53.5% 保費收入與 18.7% 醫療會員受最低醫療損失率規則約束。
  • Carelon 執行——Carelon 的快速增長(Services +57.7%)依賴第三方訂單與整合;放緩即失去多元化對沖。
  • 供應商與藥品成本——醫院、醫生與藥房(包括專科藥)價格增長壓迫每個板塊的利潤。

對標普500的重要性

信諾健康是標普500的管理式醫療對醫療成本的讀數:指數權重 0.13%、醫療保健市值第 #21,其福利支出趨勢與會員變動預示整個管理式醫療板塊的業績。

其 Carelon 業務亦是藥房與健康服務外包的讀數——即使保險利潤受壓,該部分仍在增長。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 31 日抓取)· StockAnalysis(市值——2026 年 10 月 31 日抓取)
財務信諾健康 FY2025 Form 10-K(SEC EDGAR,2026 年 2 月 6 日申報;財政年度截至 2025 年 12 月 31 日)
板塊分類GICS,據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

Elevance

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · ELV
Data as of Oct 31, 2026 · Financials FY2025 (10-K) · Market data Oct 2026
Previous · The Cigna Group (CI) — XLV Health Care · S&P 500 Profile |信諾集團介紹Next · Illinois Tool Works Inc. (ITW) — XLI Industrials · S&P 500 Profile |伊利諾伊工具介紹

Entered 2026-10-31 04:34 · updated 2026-11-14 23:23 · rev 6